These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36463141)

  • 1. Were economic evaluations well reported for the newly listed oncology drugs in China's national reimbursement drug list.
    Liu L; Jiang Z; Li F; Wei Y; Ming J; Yang Y; Liu S; Shi L; Chen Y
    BMC Health Serv Res; 2022 Dec; 22(1):1475. PubMed ID: 36463141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review.
    Yan J; Bao S; Liu L; Zhang YQ; Ming J; Wei Y; Chen Y
    Integr Med Res; 2023 Mar; 12(1):100915. PubMed ID: 36632129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English.
    Cheng J; Zhang Y; Zhong A; Tian M; Zou G; Chen X; Yu H; Song F; Zhou S
    Appl Health Econ Health Policy; 2022 Jan; 20(1):35-54. PubMed ID: 34322862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Miroshnychenko A; Uhlman K; Malone J; Waltho D; Thoma A
    J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2458-2466. PubMed ID: 34217645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of published health economic evaluations on screening programs in China: a systematic review and quantitative appraisal.
    Xia Y; Lian D; Yang Y; Si L; Ming J; Wei Y; Chen Y
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1277-1283. PubMed ID: 36226906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review.
    Bouée-Benhamiche E; Bousquet PJ; Ghabri S
    Appl Health Econ Health Policy; 2020 Aug; 18(4):491-508. PubMed ID: 32056121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the quality and trend of reporting of health economic evaluation research in India.
    Karekar S; Shetty Y
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):595-599. PubMed ID: 33249942
    [No Abstract]   [Full Text] [Related]  

  • 10. Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China.
    Zhang Y; Wei Y; Li H; Chen Y; Guo Y; Han S; Shi L; Guan X
    Pharmacoeconomics; 2022 Jul; 40(7):715-724. PubMed ID: 35764914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):e1-5. PubMed ID: 23538200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    J Med Econ; 2013; 16(6):713-9. PubMed ID: 23521434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Int J Technol Assess Health Care; 2013 Apr; 29(2):117-22. PubMed ID: 23587340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    BMJ; 2013 Mar; 346():f1049. PubMed ID: 23529982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    Eur J Health Econ; 2022 Nov; 23(8):1309-1317. PubMed ID: 35084632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    J Med Econ; 2022 Jan; 25(sup1):1-7. PubMed ID: 35012427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    Value Health; 2022 Jan; 25(1):3-9. PubMed ID: 35031096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses.
    Wang Y; Camateros P; Smith D; Dawe D; Ellis P
    Syst Rev; 2019 Jun; 8(1):139. PubMed ID: 31186068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic evaluation in orthotics and prosthetics: a systematic review protocol.
    Clarke L; Dillon M; Shiell A
    Syst Rev; 2019 Jun; 8(1):152. PubMed ID: 31248460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic evaluation on breast cancer screening in mainland China: a systematic review].
    Wang L; Shi JF; Huang HY; Zhu J; Li J; Fang Y; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Dec; 37(12):1662-1669. PubMed ID: 27998418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.